
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
A leading ophthalmology group has issued a physician advisory about a possible link between the alpha-blocker tamsulosin and a new small pupil syndrome known as intraoperative floppy iris syndrome.





